0 items USD 0.00Search
- Did you mean
- sclerosis drug
Your search for "Scleroderma drug" gave back 43 results.
This study focuses on China鈥檚 HIV Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing...
颁补迟补濒辞驳:听
Asia Market Information & Development Co.
March 2018
Price: USD 1,800.00
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
颁补迟补濒辞驳:听
AEI
June 2021
Price: USD 3,000.00
Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape Summary GBI Research's latest...
CBR Pharma Insights
March 2016
Price: USD 2,995.00
Opioids Overview to 2021 An Assessment of Pain Management and Dependence report discusses the use of opioids as potent analgesics for the treatment...
颁补迟补濒辞驳:听
CBR Pharma Insights
August 2015
Price: USD 2,995.00
North America onychomycosis treatment market is projected to grow by 7.2% annually in the forecast period and reach $2,111.2 million by 2031, driven...
颁补迟补濒辞驳:听
Grace Market Data
April 2022
Price: USD 2,800.00
Asia Pacific onychomycosis treatment market will grow by 9.3% annually with a total addressable market cap of $10,998.9 million over 2022-2031,...
颁补迟补濒辞驳:听
Grace Market Data
April 2022
Price: USD 2,800.00
North America onychomycosis treatment market is projected to grow by 7.2% annually in the forecast period and reach $2,111.2 million by 2031, driven...
颁补迟补濒辞驳:听
Grace Market Data
April 2022
Price: USD 2,800.00
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report, "Innovation Tracking...
CBR Pharma Insights
June 2016
Price: USD 2,995.00
Global onychomycosis treatment market will reach $5,787.4 million by 2031, growing by 7.9% annually over 2021-2031, driven by the increasing...
颁补迟补濒辞驳:听
Grace Market Data
April 2022
Price: USD 3,400.00
The United States market for pain management therapeutics remains a substantial growth area for pharmaceutical companies, as they continue their...
颁补迟补濒辞驳:听
iGATE
September 2017
Price: USD 1,100.00
The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections provides a competitor evaluation in the field of...
颁补迟补濒辞驳:听
La Merie Publishing
October 2014
Price: USD 254.00
The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competitor evaluation in the field of...
颁补迟补濒辞驳:听
La Merie Publishing
September 2014
Price: USD 254.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2018
Price: USD 2,995.00
听
